- Bayer Group
- Key Messages to Investors
- About Bayer
- Mission & Values
- Strategic Alignment
- Opportunity and Risk Report
- Corporate Governance
- Articles of Incorporation
- Board of Management
- Supervisory Board
- Sustainability and Commitment
- New Investor
- Listing and Key Figures
- Share Price
- Stockholders' Portal
- Ownership Structure
- Stock Programs
- Stock History
- Annual Stockholders’ Meeting 2016
- Live Events
- Investor Conferences
- Stockholders' Meeting
- Press Conferences
- Other Presentations
- Ad-hoc Publications
- Investor News
Answers to our investors' frequently asked questions:
On August 1, 1863 businessman Friedrich Bayer and master dyer Johann Friedrich Weskott established a dyestuffs factory in Barmen, now a part of Wuppertal. Soon afterwards, in 1865, the two men purchased an interest in a coal tar dye factory in the United States and began exporting intermediates. In 1876 a dyestuffs factory was opened in Moscow. The descendants of Bayer and Weskott established the joint stock company Farbenfabriken vorm. Friedr. Bayer & Co. on July 1, 1881. The Flers plant in northern France started production in 1883. In 1884 the chemist Carl Duisberg began his career at Bayer. Under his management, Bayer scientists made pioneering discoveries. The Pharmaceutical Department was established in 1888. In 1891 the Leverkusen site was purchased. Bayer researcher Dr. Felix Hoffmann first synthesized acetylsalicylic acid in a chemically pure and stable form in 1897. Aspirin® was registered as a trademark in 1899 and became the world's favorite pain killer. In 1912 the company's headquarters were transferred to Leverkusen. Farbenfabriken vorm. Friedr. Bayer & Co. merged with other companies to form I.G. Farbenindustrie AG in 1925. Leverkusen became the main production center of the I.G.'s Lower Rhine operating consortium. Following the Second World War, the Allies seized and later broke up I.G. Farben. Bayer was re-established as Farbenfabriken Bayer AG in 1951 and changed its name to Bayer AG in 1972. The push for expansion as an international health care and chemicals group began.
In 2013 the Bayer Group is celebrating its 150th anniversary.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.
As of December 31, 2015 the number of employees in the Bayer Group was 116,800.
|- there of Germany||36,700|
|Asia / Pacific||28,800|
|Latin America / Middle East / Africa||16,100|
For fiscal 2015 the Bayer Group reported net sales of € 46,324 million and EBITDA before special items of € 10,266 million.
With the company’s focus now on the Life Science businesses, a new organizational structure was introduced effective January 1, 2016. The company’s operations are now managed in three divisions – Pharmaceuticals, Consumer Health and Crop Science – and the Animal Health business unit. Bayer currently still owns around 69% of Covestro AG.
2015 Pro Forma Key Data by New Segment
The consolidated financial statements of the Bayer Group as of December 31, 2015, were prepared by BayerAktiengesellschaft (Bayer AG) according to the International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board (IASB), London, and the interpretations of the IFRS Interpretations Committee (IFRS IC), both as endorsed by the European Union and in effect at the end of the reporting period. The applicable further requirements of Section 315a of the German Commercial Code were also taken into account.
The fiscal year is the calendar year.
Bayer welcomes the Corporate Governance Code. We have a long-standing committment to these principles in the interest of value creation.
All publications can be ordered or subscribed from our website Publications. After selecting the documents you need, you will be prompted to enter all information required for ordering.
The Bayer stock was listed for the first time on October 2, 1953 on the Frankfurt Stock Exchange.
How to invest in Bayer shares?
The capital stock of Bayer AG is traded as no-par registered shares on electonic trading platformas like Xetra® as well as at several stock exchanges. You can buy Bayer ordinary shares through any supplier of brokerage services, usually banks. To do so, you need a custody account in which your shares are administered. It is not possible to acquire the shares directly through Bayer.
How to buy Bayer ADRs?
In the United States, Bayer stock has been traded under a OTC Level l ADR Program since September 27, 2007. The ticker symbol is BAYRY. Trading information is obtainable from the Pinksheets OTC website.
Bayer ADRs are issued by The Bank of New York Mellon, acting as depositary.
Under the German Securities Trading Act (Wertpapierhandelsgesetz), holders of voting securities of a listed German company must notify that company of the level of their holding whenever it reaches, exceeds or falls below specified thresholds. These thresholds are 3, 5, 10, 15, 20, 25, 30, 50 and 75 percent of the company’s outstanding voting securities.
To motivate and enhance their performance, Bayer allows its employees to benefit directly from the company's success. We offer three different programs for defined participant groups. Eligibility for the different programs varies with an employee’s position in the company, since people at higher levels of management are considered to have a greater direct influence on the company’s economic performance and thus on the performance of Bayer stock. Bayer therefore offers the stock program Aspire for members of the Board of Management, for other Group Executives (members of the “Group Leadership Circles”), and for other senior managers, and a Stock Participation Program for all other groups of employees.
Information about the dividend for fiscal 2015
Conforming to the proposal of the Board of Management and the Supervisory Board, the Annual Stockholders’ Meeting on April 29, 2016 passed the resolution to pay a dividend for fiscal 2015 of EUR 2.50 per share.
The resulting payout ratio of 37 percent calculated on core earnings per share is within our target corridor of 30 percent to 40 percent (for details of the calculation of core earnings per share, see Annual Report 2015, Chapter 14.3 of the Combined Management Report).
The dividend yield calculated on the share price of €115.80 at year end 2015 amounts to 2.2 percent and the total dividend payment to €2,067 million.
The next Ordinary Stockholders' Meeting of Bayer AG will take place on Friday, April 28, 2017.
The former MaterialScience subgroup became a separate economic and legal entity on September 1, 2015, and operates under the name Covestro. Covestro AG was floated on the stock market on October 6, 2015. Bayer currently still owns around 64% of Covestro AG, which is therefore still included in the Consolidated Financial Statements of Bayer as a fully consolidated subsidiary.